Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EGCG Octaacetate, a prodrug of EGCG, is utilized to enhance the stability and bioavailability of EGCG in vivo. It has high efficacy, bioavailability, anti-oxidation, and anti-angiogenesis capacities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 80.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 130.00 |
Description | EGCG Octaacetate, a prodrug of EGCG, is utilized to enhance the stability and bioavailability of EGCG in vivo. It has high efficacy, bioavailability, anti-oxidation, and anti-angiogenesis capacities. |
Source |
Molecular Weight | 794.67 |
Formula | C38H34O19 |
CAS No. | 148707-39-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (34.61 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EGCG Octaacetate 148707-39-5 Microbiology/Virology Others Antibacterial Inhibitor prodrug gram-negative bacteria Bacterial inhibit colitis-driven colon cancer PI3K/Akt/NFκB phosphorylation AcEGCG EGCG p65 acetylation gram-positive bacteria inhibitor